Document Title: SELECT NEWS RELEASES  Updated October 13, 2000

  1. SYNSORB BIOTECH INC. REPORTS FIRST QUARTER 2002 RESULTS (Thursday, May 30, 2002)

  2. SYNSORB Updates Shareholders on Consolidation & Distribution Details and on Manufacturing Facility Sale (Wednesday, May 15, 2002)

  3. SYNSORB Biotech Inc. Shareholders Elect a New Board of Directors and Approve Plan of Arrangement (Tuesday, May 07, 2002)

  4. SYNSORB Reaches Agreement to Sell Manufacturing Facility (Monday, May 06, 2002)

  5. SYNSORB Reminds Shareholders to Vote Their Proxies by Friday May 3, 2002 (Wednesday, May 01, 2002)

  6. SYNSORB Biotech Inc. Provides Corporate Update and Reports Year-End 2001 Results (Tuesday, April 09, 2002)

  7. SYNSORB Biotech Inc. and Oncolytics Biotech Inc. Announce Regulatory Approval to Distribute Oncolytics' Shares held by SYNSORB to SYNSORB Shareholders (Thursday, March 28, 2002)

  8. SYNSORB Announces Changes to Senior Management and Board of Directors (Tuesday, March 19, 2002)

  9. SYNSORB Press Release (Friday, February 08, 2002)

  10. SYNSORB Announces Close of Secondary Offering of Oncolytics Shares (Thursday, January 31, 2002)

  11. SYNSORB Advised of Law Suit (Tuesday, January 22, 2002)

  12. SYNSORB Announces $5.7 Million Bought Deal of Oncolytics Shares (Tuesday, January 22, 2002)

  13. SYNSORB ANNOUNCES CORPORATE UPDATE Company completes first phase of staff reductions, restructures debt and plans divestiture of assets (Monday, January 14, 2002)

  14. SYNSORB ANNOUNCES TERMINATION OF SYNSORB-Cd DEVELOPMENT PROGRAM -Company plans to focus efforts on new strategic opportunities- (Monday, December 10, 2001)

  15. SYNSORB Receives Second Milestone Payment of BCY Shares (Friday, November 09, 2001)

  16. SYNSORB Reports Third Quarter 2001 Financial Results Results meet Company's expectations (Wednesday, November 07, 2001)

  17. SYNSORB to present at Techvest, LLC Third Annual Healthcare Conference (Monday, October 22, 2001)

  18. SYNSORB Announces Expansion of Scientific Advisory Board (Tuesday, October 02, 2001)

  19. SYNSORB concludes the first transfer of shares of Oncolytics (Thursday, August 09, 2001)

  20. SYNSORB receives milestone payment from MDS Proteomics (Wednesday, July 11, 2001)

  21. SYNSORB Receives Milestone Payment of BCY Shares (Wednesday, June 06, 2001)

  22. SYNSORB Announces Agreement for Sale of Oncolytics Shares (Thursday, May 31, 2001)

  23. SYNSORB Biotech Provides Corporate Update at AGM (Thursday, May 03, 2001)

  24. SYNSORB to host Annual General Meeting, Thursday May 3, 2001 (Tuesday, April 24, 2001)

  25. SYNSORB Announces Changes to Management of SYNSORB Cd Program (Wednesday, April 04, 2001)

  26. 2000 ANNUAL REPORT NOW AVAILABLE (Tuesday, April 03, 2001)

  27. Dr. David Cox interviewed by Wall Street Reporter.com (Thursday, March 22, 2001)

  28. SYNSORB Appoints Vice President Finance & CFO (Wednesday, March 07, 2001)

  29. Dr. David Cox interviewed by CEOCast.com (Monday, March 05, 2001)

  30. SYNSORB Releases Year End and Fourth Quarter Financials (Friday, March 02, 2001)

  31. SYNSORB Webcast of Conference Call (Thursday, December 14, 2000)

  32. SYNSORB Announces Update to Product Development Strategy (Thursday, December 14, 2000)

  33. SYNSORB Affiliate Oncolytics Signs Deal with Pfizer (Monday, November 20, 2000)

  34. SYNSORB REPORTS THIRD QUARTER RESULTS (Monday, November 20, 2000)

  35. SYNSORB Announces Update on SYNSORB Pk(R) Development Program (Tuesday, September 26, 2000)

  36. SYNSORB REPORTS SECOND QUARTER RESULTS (Thursday, August 17, 2000)

  37. SYNSORB to Host Dial-In Conference Call for Investors (Friday, July 14, 2000)

  38. SYNSORB Announces Final Phase II Results for SYNSORB CdŽ (Thursday, July 06, 2000)

  39. SYNSORB Receives Milestone Payment (Tuesday, June 27, 2000)

  40. SYNSORB Biotech Inc. Reports First Quarter Results (Friday, May 19, 2000)

  41. SYNSORB Receives Issued Patent & Notice of Allowance (Thursday, May 18, 2000)

  42. SYNSORB Launches SYNSORB Cd(R) Phase III Clinical Trials (Monday, April 03, 2000)

  43. SYNSORB Receives 1.1 Million BCY Shares (Thursday, March 16, 2000)

  44. SYNSORB Announces Sale of INH Technologies Inc. to MDS (Tuesday, March 07, 2000)

  45. SYNSORB Biotech Inc. Reports 1999 Consolidated Results (Friday, February 25, 2000)

  46. SYNSORB Biotech Inc. Signs Agreement With BCY Ventures Inc. (Friday, February 11, 2000)

  47. SYNSORB Biotech Inc. Completes $24 Million Bought Deal (Wednesday, February 02, 2000)

  48. SYNSORB Biotech Inc. Announces Filing of Final Prospectus (Tuesday, January 25, 2000)

  49. SYNSORB Biotech Inc. Bought Deal Increased to $21 Million (Wednesday, January 12, 2000)

  50. SYNSORB Cd receives Fast Track Product Designation from US FDA (Tuesday, January 11, 2000)



Investor Relations SYNSORB Biotech Inc.
410, 1167 Kensington Crescent NW
Calgary, Alberta, Canada T2N 1X7

Voice Line:
Facsimile :

https://SYNSORB.com

Copyright © 2001 SYNSORB Biotech Inc.